AML, Childhood Clinical Trials

9 clinical trials for AML, Childhood across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML — RECRUITING · PHASE1
• CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies — RECRUITING · PHASE1
• Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation — RECRUITING · PHASE2
• Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML — RECRUITING · PHASE2
• Retun-to-school Adaptation Program for Children With Cancer — COMPLETED · NA
• ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML — WITHDRAWN · PHASE1
• A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia — TERMINATED · PHASE1
• Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML — OTHER · PHASE1
• AflacLL1901 (CHOA-AML) — TERMINATED · PHASE2

Refine this search